Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma

JL Joyal, JA Barrett, JC Marquis, J Chen, SM Hillier… - Cancer research, 2010 - AACR
… with a Gamma Medica X-SPECT scanner equipped with two medium-… Uptake in the thyroid
was also visualized beginning at 24 … N-(2-diethylamino-ethyl 4-iodobenzamide; BZA), the first …

Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and 14C-I-BZA

F Chéhadé, C de Labriolle-Vaylet… - Journal of Nuclear …, 2005 - Soc Nuclear Med
… of N-(2-diethylaminoethyl)-4-iodobenzamide (I-BZA), a … in patients with cutaneous or ocular
melanoma in a phase II trial … The distribution of 14 CI-BZA is visualized by dual detection of …

Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting

P Labarre, J Papon, MF Moreau, N Moins… - European journal of …, 1999 - Springer
… For one of them, ortho-N(2-diethylaminoethyl)-4-iodobenzamide, liver and lung … Visualizing
ocular melanoma using iodine-123-N-(2-diethylamonoethyl)-4 iodobenzamide SPECT

Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52

W Mier, C Kratochwil, JC Hassel… - Journal of Nuclear …, 2014 - Soc Nuclear Med
… The 10-min images were dominated by perfusion (ie, visualization of vessels and heart)…
using the derivate 125 I-N-(2-diethylaminoethyl) 4-iodobenzamide for imaging in 110 melanoma

Ocular melanoma and other unusual sites

G Grassetto, D Fuster, A Alavi, D Rubello - PET clinics, 2011 - pet.theclinics.com
… Cutaneous melanoma is the most frequent kind of melanoma, whereas only 4% to 5% of all
malignant melanomas arise from an extracutaneous site. Among these, ocular melanoma is …

[HTML][HTML] Development of Radiofluorinated Nicotinamide/Picolinamide Derivatives as Diagnostic Probes for the Detection of Melanoma

YH Lo, TY Chang, CL Chen, MH Lin, HE Wang… - International Journal of …, 2021 - mdpi.com
… B16 melanoma (6.75 %ID/g) and liver (6.04 %ID/g) at 1 h after intravenous injection [6]. The
first clinical trial of 123 IN-(2-diethylaminoethyl)4-Iodobenzamide ( … to ocular melanoma, eye

Promising pre-clinical validation of targeted radionuclide therapy using a [131I] labelled iodoquinoxaline derivative for an effective melanoma treatment

M Bonnet-Duquennoy, J Papon, F Mishellany… - 2009 - dro.deakin.edu.au
using an adaptation of the MIRD program. From this study a quinoxaline derivative molecule
(N-(2-diethylaminoethyl)-6… uveal uptake was imaged excepted for an ocular melanoma case …

Imaging malignant melanoma with 18F-5-FPN

H Feng, X Xia, C Li, Y Song, C Qin, Q Liu… - European journal of …, 2016 - Springer
… The higher sensitivity of PET and SPECT in many … The kidneys and bladder were visualized
in all animals, demonstrating … -[2-diethylamino-ethyl]4-iodobenzamide) (iodoBZA) labelled …

Molecular probes for malignant melanoma imaging

G Ren, Y Pan, Z Cheng - Current pharmaceutical …, 2010 - ingentaconnect.com
… as well as lung and liver metastases could be clearly visualized … for the detection of ocular
melanoma. Both 14C labeled DL-, L- … of n-(2-diethylaminoethyl)-4iodobenzamide, an effective …

[PDF][PDF] Melanoma, imaging

MG Niebling, E Bastiaannet, OS Hoekstra… - … in Melanoma, 2013 - research.rug.nl
… Fab2 of the antibody 255-28 S for detection of ocular melanoma. 33 However, wider …
technique available to visualize the dynamic process of lymphatic drainage. Therefore SPECT/CT …